Medtronic's Arctic Front becomes first PAF cryoballoon in the US
This article was originally published in Clinica
Executive Summary
The US FDA has granted premarket approval (PMA) for Medtronic's Arctic Front cardiac cryoablation catheter. The Minneapolis, Minnesota firm claims the minimally-invasive device is the first and only cryoballoon in the US indicated for the treatment of drug-refractory paroxysmal atrial fibrillation (PAF).